Cargando…
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
Autores principales: | Liu, Xiaohui, Zheng, Weimin, Wang, Wansheng, Shen, Huali, Liu, Linxiao, Lou, Wenhui, Wang, Xiaolin, Yang, Pengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908675/ https://www.ncbi.nlm.nih.gov/pubmed/29438371 http://dx.doi.org/10.1038/bjc.2018.5 |
Ejemplares similares
-
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
por: Liu, Xiaohui, et al.
Publicado: (2017) -
Correction to “Mass spectrometry‐based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways”
Publicado: (2023) -
CORRIGENDUM: Addition of data source: Diagnostic model for pancreatic cancer using a multi-biomarker panel
por: Choi, Yoo Jin, et al.
Publicado: (2021) -
Corrigendum to “Identification of In Vivo Metabolites of Dictamnine in Mice Using HPLC-LTQ-Orbitrap Mass Spectrometry”
por: Fu, Yudong, et al.
Publicado: (2019) -
Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
por: Kuhlin, Johanna, et al.
Publicado: (2022)